Dengue serotype 2 attenuated strain

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8795688
APP PUB NO 20120083585A1
SERIAL NO

13281255

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFI PASTEUR69367 LYON CEDEX 07

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barban, Véronique Craponne, FR 10 64
Guy, Bruno Lyons, FR 25 180
Kinney, Claire Y H Fort Collins, US 16 145
Kinney, Richard Fort Collins, US 10 50
Lang, Jean Mions, FR 17 136

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 5, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00